(Q44693016)

English

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

venous thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B I Eriksson

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

G Agnelli

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A T Cohen

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

O E Dahl

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M R Lassen

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

P Mouret

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

N Rosencher

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

P Kälebo

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

S Panfilov

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

C Eskilson

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M Andersson

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A Freij

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

EXPRESS Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2490-2496

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Managing oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Ventilation-perfusion studies in suspected pulmonary embolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2003.00494.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2003.00494.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44693016&oldid=2104985086"